- Home
- KALV vs TBLD Comparison
KALV vs TBLD Comparison
Compare KALV & TBLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- TBLD
- Stock Information
- Founded
- KALV N/A
- TBLD 2021
- Country
- KALV United States
- TBLD United States
- Employees
- KALV N/A
- TBLD N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- TBLD Investment Managers
- Sector
- KALV Health Care
- TBLD Finance
- Exchange
- KALV Nasdaq
- TBLD Nasdaq
- Market Cap
- KALV 642.3M
- TBLD 543.1M
- IPO Year
- KALV N/A
- TBLD N/A
- Fundamental
- Price
- KALV $14.31
- TBLD $19.19
- Analyst Decision
- KALV Strong Buy
- TBLD
- Analyst Count
- KALV 9
- TBLD 0
- Target Price
- KALV $26.29
- TBLD N/A
- AVG Volume (30 Days)
- KALV 2.0M
- TBLD 76.0K
- Earning Date
- KALV 07-10-2025
- TBLD 01-01-0001
- Dividend Yield
- KALV N/A
- TBLD 6.48%
- EPS Growth
- KALV N/A
- TBLD N/A
- EPS
- KALV N/A
- TBLD N/A
- Revenue
- KALV N/A
- TBLD N/A
- Revenue This Year
- KALV N/A
- TBLD N/A
- Revenue Next Year
- KALV $347.19
- TBLD N/A
- P/E Ratio
- KALV N/A
- TBLD N/A
- Revenue Growth
- KALV N/A
- TBLD N/A
- 52 Week Low
- KALV $7.30
- TBLD $15.80
- 52 Week High
- KALV $16.32
- TBLD $19.97
- Technical
- Relative Strength Index (RSI)
- KALV 58.58
- TBLD 51.47
- Support Level
- KALV $11.10
- TBLD $19.15
- Resistance Level
- KALV $16.32
- TBLD $19.90
- Average True Range (ATR)
- KALV 1.10
- TBLD 0.39
- MACD
- KALV 0.36
- TBLD -0.05
- Stochastic Oscillator
- KALV 68.95
- TBLD 36.07
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About TBLD Thornburg Income Builder Opportunities Trust
Thornburg Income Builder Opportunities Trust is a diversified, closed-end management investment company. The Trust's investment objective is to provide current income. The Trust will seek to achieve its investment objective by investing, directly or indirectly, at least 80% of its Managed Assets.